Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Disease Progression × tivozanib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 2 Disease Progression 1

Interventions

Lenalidomide 3 capivasertib 2 Bortezomib 2 tivozanib 1 Zoledronic Acid 1 Vitamin D 1 Temozolomide 1 Radiotherapy 1 Nivolumab 1 Fulvestrant 1 Etoposide 1 Dexamethasone 1 Cisplatin 1 Carboplatin 1 Calcium Dobesilate 1 Calcium 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04987203 2025-08-22

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

AVEO Pharmaceuticals, Inc.

Phase 3 Active not recruiting

Carcinoma, Renal Cell, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡